PARP Inhibition - basic science and clinical challenge

The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Has this module enabled you to understand a rationale from available preclinical data for a clinical development of PARP inhibitors? (1-not at all; 5-absolutely)

2. Has this module enabled you to be familiar with current understanding of the mechanism of action of PARP inhibitors? (1-not at all; 5-absolutely)

3. Has this module enabled you to understand the current research and potential clinical translation of PARP inhibitors for the anti-cancer therapy? (1-not at all; 5-absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: